BioSpace News Archive

Vigeo Therapeutics announced that Jing Watnick, president and chief executive officer, will present at the BIO Investor Forum on Wednesday, October 23, 2019 at 10:00 am PT at the Westin St. Francis in San Francisco.

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that the Company will present at the MicroCap Rodeo on Oct 16th at 9:45-10:15 AM in room 416B.

Journal Reports OTL38 Reveals Undetected Cancer in 48% of Patients

Mouse Embryo Assay Provides Proof of Concept Comparing Conventional Dewars and TMRW’s Cryo Robot

Hoth Therapeutics, Inc announced that Robb Knie, Chief Executive Officer, will be presenting at the Dawson James 5th Annual Small Cap Growth Conference which is being held October 28-29, 2019 at the Wyndham Grand Hotel in Jupiter, Florida.

Aevi Genomic Medicine, Inc. announced that the Nasdaq Hearings Panel has agreed to the transfer of the Company’s shares to the Nasdaq Capital Market effective at the open of business on October 15, 2019 and granted the Company until February 3, 2020 to gain and evidence compliance of the Nasdaq Capital Market continued listing requirements..

Country music artist Chris Young visits St. Jude to kick off launch of new playlists

Findings show that REL-1017 has rapid onset and sustained antidepressant efficacy with statistically significant differences compared to placebo on all efficacy measures

At 5:00 p.m. Eastern Time (ET), senior management will host a conference call to review the Company’s financial performance.

The National Institute on Drug Abuse (NIDA) has awarded a grant to EicOsis LLC as part of the NIH initiative Helping to End Addiction Long-Term (HEAL Initiative) to support human clinical trials of a novel compound that has been found effective for the treatment of pain in preclinical animal studies